Note: This web page has been under construction for ONE YEAR. With the appearance of the current coronavirus, we want to clarify that any information or discussion related to the control of the pandemic in any country or region, should only be looked for on official governmental communications.
TERA Biotechnology is inviting all persons interested in the knowledge of infectious diseases, control, use of containment methodology and knowledge of biological products to control them, to join us in a brand-new platform of dynamic intellectual exchange.
Here you can read opinions from world leading experts in all these topics and you can ask questions in order to clarify issues that affect specific areas of your community. Readers can also suggest subjects, specific diseases and or controversial issues where more information and discussion is needed.
The information that is going to be available, will cover several levels of knowledge, starting from the general public up to health science professionals and personnel. Specific laboratory procedures for biological processes will also be included. People across the world are now interested on the features of pandemics. There is a need for detailed and accurate facts and general knowledge of so many infectious diseases. Especially those that are being transmitted from animals to the human population, considerable attention should be given to the “One health integrated approach”.
There is a need, both in developed and developing nations, to review the capacity to handle the containment of infectious diseases, the handling and use of biological products and their production systems, to be able to sustain preventive health programs allowing them to gain an effective control over the sale and distribution of biological products. The knowledge of a broad spectrum of infectious diseases transmitted from animals to humans is of paramount importance to everybody, at all levels, since anyone could be affected it becomes of importance to investigate the zoonotic diseases and the infection origins of viruses in humans
Current trends in infectious diseases that are being transmitted from animals to human populations.
Epidemiology and containment of some of the current most significant infectious diseases that affect large populations in the world.
Technologies for the production, evaluation and quality control of vaccines for human and animal use.
Evaluation on the use and application of major vaccines in the world.
Specially designed systems that could be utilized for the in-vitro cultivation of cells and viruses.
Laboratory procedures for in-vitro, cell, virus and bacterial cultivation under high densities and in semi-continuous systems.
Procedures for the downstream production processes of biological products including the latest purification methodology.
Quality assurance of microbiological systems, including containment, management of clean rooms, handling and storage of materials.
Laboratory ethical and practical considerations in animal testing of biological products.
Design of biological laboratories, of vaccine production facilities and of laboratory animal safety buildings.
In TERA Biotechnology we have scientific experts with considerable years of experience in epidemiology of diseases transmitted from animals to humans, in research, in industrial production processes of biologicals, in quality assurance and quality control of facilities that comply with Good Manufacturing Practices. Our expertise also covers cross contamination control, preparation of purified materials, and containment and isolation methodology. We have professionals readily accessible when needed on the fields of Virology, Medicine, Microbiology, Biochemistry, Veterinary Medicine, Bacteriology Nursing, Dentistry, and Biology.
For the last twenty years, consultants from TERA Biotechnology, have been committed to numerous consultancies in the epidemiology of diseases, the production, quality control, and use of biologicals for human and animal use. The most outstanding carried out in Egypt, Thailand, Philippines, India, South Korea, Mexico and Peru. Recently, consultancies have been attended in several Chinese cities including Nanjing, Shanghai, Chengdu, Changzhou, Shenyang, Hohhot, Harbin and Lanzhou.
Note: This web page has been under construction for the last three years. With the appearance of the current coronavirus, we want to clarify that any information or discussion related to the control of the pandemic in any country or region, should only be looked for on official governmental communications.